APA (7th ed.) Citation

Musadiq, M., Musadiq, M., Latif, F., Ng, B., Azzopardi, M., Gilead, N., . . . Chong, Y. J. Early Real-World Outcomes of Switching to 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration in the United Kingdom. MDPI AG.

Chicago Style (17th ed.) Citation

Musadiq, Muiz, Mohammed Musadiq, Fozia Latif, Benjamin Ng, Matthew Azzopardi, Noa Gilead, Andrew Needham, and Yu Jeat Chong. Early Real-World Outcomes of Switching to 8 Mg Aflibercept for Neovascular Age-Related Macular Degeneration in the United Kingdom. MDPI AG.

MLA (9th ed.) Citation

Musadiq, Muiz, et al. Early Real-World Outcomes of Switching to 8 Mg Aflibercept for Neovascular Age-Related Macular Degeneration in the United Kingdom. MDPI AG.